Protecting the brain after cardiac arrest

By Jan Jarvis

Mallet_web

A new treatment identified by UNT Health Science researchers may protect the brain from irreversible brain damage caused by cardiac arrest.

The discovery, published in the May issue of Experimental Biology and Medicine, could offer hope to the more than 500,000 people in the United States who suffer a cardiac arrest each year. Currently there are few treatments available to help these patients.

The brain consumes enormous amounts of metabolic energy and is dependent on its blood supply to deliver energy-yielding fuels and oxygen. When the brain’s blood supply is interrupted, such as during a cardiac arrest, the brain rapidly depletes its energy reserves and toxic metabolites accumulate.

This leads to damage in the molecular components of the brain’s cells, including proteins. As a result, only 8 percent of those who suffer a cardiac arrest outside the hospital survive with brain function intact, said Robert Mallet, PhD, Professor, Institute for Cardiovascular and Metabolic Disease.

“Cardiac arrest is devastating because it severely injures the brain,” Dr. Mallet said. “Moreover, those who are fortunate enough to survive cardiac arrest may be at increased risk of developing senile dementia.”

Cardiac arrest triggers the production of the metabolite methylglyoxal, a byproduct of sugar metabolism that damages proteins and may cause permanent impairment of brain function. In the lab, a research team led by Dr. Mallet found that glyoxalase and other protective enzymes were inactivated following cardiac arrest and CPR, weakening the brain’s natural defenses against methylglyoxal and other toxins.

But giving patients an intravenous infusion of an energy fuel and antioxidant called pyruvate may restore these defenses and preserve functional brain proteins, according to the study. Pyruvate is a natural metabolite that protects the brain against methylglyoxal when given in a timely fashion, Dr. Mallet said.

“Pyruvate could be an ideal brain protectant because it is effective in humans, is chemically stable and has no adverse side effects,” Dr. Mallet said.

Recent News

Ih D Conference Main
  • On Campus
|May 25, 2023

HSC’s Institute for Health Disparities to host ‘Engaging the Whole Person’ conference

The public is invited to learn more about whole health, including the actions and barriers to achieving health equity for minorities, at this year’s 18th Annual Texas Conference on Health Disparities at The University of North Texas Health Science Center at Fort Worth. “Engaging the Whole Per...
Aleesia Isom
  • Community
|May 25, 2023

Alumna Aleesia Isom found purpose in HSC's School of Health Professions

A passion for education and empowerment took recent The University of North Texas Health Science Center at Fort Worth Doctor of Physical Therapy graduate Aleesia Isom from the classroom to the clinic. In 2014, Isom began her elementary education career as a science teacher in Memphis, Tennessee. ...
Telehealth
  • On Campus
|May 24, 2023

New app to focus on telementoring to improve rural health care

The pandemic brought telecommunication technology to the front lines of health care. A growing body of evidence shows that telementoring — the practice of using technology to guide less experienced health care workers from afar — can improve rural health by building local capacity to treat ...
Commencenent Main
  • Community
|May 23, 2023

TCOM celebrates its 50th graduating class of osteopathic physicians

On Monday, June 3, 1974, the legendary pathologist and osteopathic physician Dr. Otterbein Dressler gave the keynote address at the William Edrington Scott Theatre to 18 newly minted osteopathic physicians from the burgeoning Texas College of Osteopathic Medicine in Fort Worth. Little did Dressle...